CD4 and neoplasm: Unlike the pancreatic model that relies on nonspecific tumor markers, our approach incorporates HIV-specific immunological parameters including CD3+ and CD4+ T cell counts, which directly reflect the underlying pathophysiological mechanisms of lymphomagenesis in immunodeficient hosts.